Hap Trading, LLC Durect Corp Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $11,250 - $16,375	-12,500 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$1.21 - $1.61 $2,420 - $3,220	2,000 Added 19.05%	12,500 $0
Q2 2021 Aug 11, 2021	SELL	$1.6 - $2.02 $15,360 - $19,392	-9,600 Reduced 47.76%	10,500 $1,000
Q1 2021 May 14, 2021	BUY	$1.86 - $2.87 $37,386 - $57,687	20,100 New	20,100 $4,000
Q4 2020 Feb 16, 2021	SELL	$1.65 - $2.43 $27,720 - $40,824	-16,800 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.6 - $2.35 $1,280 - $1,880	800 Added 5.0%	16,800 $6,000
Q2 2020 Aug 10, 2020	BUY	$1.33 - $2.76 $21,280 - $44,160	16,000 New	16,000 $36,000
Q1 2020 May 08, 2020	SELL	$0.97 - $2.85 $13,677 - $40,185	-14,100 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$1.69 - $3.8 $23,829 - $53,580	14,100 New	14,100 $10,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $223M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.